Ignite Creation Date:
2025-12-24 @ 4:55 PM
Ignite Modification Date:
2026-03-10 @ 4:08 AM
Study NCT ID:
NCT02465450
Status:
COMPLETED
Last Update Posted:
2018-04-04
First Post:
2015-06-04
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Tolerability, Pharmacokinetics, and Efficacy of JBT-101 (Lenabasum) in Cystic Fibrosis
Sponsor:
Corbus Pharmaceuticals Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
JBT101-CF-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None